DBRG vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

DBRG

51.5
AI Score
VS
DBRG Wins

CNS

38.7
AI Score

Investment Advisor Scores

DBRG

52score
Recommendation
HOLD

CNS

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric DBRG CNS Winner
Forward P/E 13.9665 22.3714 DBRG
PEG Ratio 3.0554 2.0458 CNS
Revenue Growth 58.9% 12.2% DBRG
Earnings Growth 1099.3% 31.9% DBRG
Tradestie Score 51.5/100 38.7/100 DBRG
Profit Margin 54.3% 28.8% DBRG
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL DBRG

Relative Price Performance (Last 90 Days)

DBRG 1M: +0.6% · 3M: +1.5% CNS 1M: +1.8% · 3M: +12.8%

Current Technical Phase

DBRG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 61

RSI (14): 60.7 · Price: $15.93

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $81.42

Fundamentals Snapshot

Metric DBRG CNS
Market Cap
Forward P/E 19.4 20.5
Trailing P/E 10.0 25.0
Revenue (TTM)
Revenue Growth 0.6% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.5% 0.3%
EPS 1.59 3.23
Dividend Yield 0.00% 0.03%

Frequently Asked Questions

Based on our detailed analysis, DBRG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.